Dr. Benjamin Bitler of the University of Colorado is a 2022 recipient of OCRA’s Collaborative Research Development Grant. His OCRA-funded project, which is expanding on findings from the Ovarian Cancer Research Group at the University of Colorado, aims to harness cutting-edge molecular profiling and advanced computational analysis in order to predict ovarian cancer recurrence and provide … Continued
In a profile with Westfair Business Journal, OCRA’s President & CEO Audra Moran speaks about her background, the direction of ovarian cancer research and prevention, and how OCRA’s programs are moving the needle forward. Read the full article, “Unlocking the secrets of ovarian cancer,” written by Georgette Gouveia and published on August 4, 2023.
September is the official month for Ovarian Cancer Awareness. Ovarian Cancer Awareness Month is our time to spread the word about risk and prevention, rally for more scientific research, and make progress toward a cure. Read on for ways you can be an ambassador for Ovarian Cancer Awareness Month! Here’s how you can make a … Continued
No, a Pap smear does not test for ovarian cancer; it screens for cervical cancer. In fact, no reliable screening or early detection tests exist for ovarian cancer. What is a Pap Smear? In the realm of women’s health, a prevalent question emerges: “Does a Pap smear reveal ovarian cancer?” This inquiry stems from a … Continued
OCRA-Funded Study Targets Immunotherapy OCRA grantees and their Roswell Park Comprehensive Cancer Center colleagues published results from an exciting study detailing a new approach to adoptive T-cell therapy that may help improve immunotherapy options for ovarian cancer patients. Learn more about the findings from the research team, which included Dr. Bob McGray, OCRA grantee, and Dr. Kunle Odunsi, … Continued
A recent study from Cancer Nursing has shed more light on the profound impact gynecologic cancer has on survivors, even after treatment. In particular, the study highlighted the prevalence of fear of recurrence among gynecologic cancer survivors, regardless of their prognosis, and underscores the importance of support programs to address survivors’ needs adequately. Through in-depth … Continued
Dr. Chi Lam Au Yeung of the University of Texas MD Anderson Cancer Center is a 2022 recipient of OCRA’s Early Career Investigator Grant. Her OCRA-funded project is focused on studying molecules produced by ovarian cancer cells in order to gain new insights into the interrelationship between different cell types in the progression of this … Continued
Two groups of golf aficionados are stirring up some playful competition this summer to raise funds for a serious cause: ovarian cancer research. And though their charity tournaments are separate from each other, both groups of OCRA Heroes had the same motivation to give back to the ovarian cancer community. They were moved by incredible … Continued
Fewer people each year are being diagnosed with ovarian cancer. Why do you feel the numbers are decreasing? OCRA’s Scientific Advisory Committee (SAC) is composed of doctors and researchers who are well-known and well-respected experts in the field of gynecologic oncology. They review the proposals we receive for research funding — hundreds of letters of … Continued
TODAY show contributor Jill Martin opened up about her recent breast cancer diagnosis, and urged viewers to speak with their doctors to see if genetic testing is warranted. Says Martin, “I am telling this story now because I couldn’t go through months of operations, and start to recover both physically and mentally, without shouting from … Continued
Snap summary: OCRA-funded researchers set out to improve immune response against a known therapeutic target, and provided a glimpse into a world where an ovarian cancer patient’s own immune system can be harnessed to treat and eradicate the disease. Researchers at Roswell Park Comprehensive Cancer Center have made significant gains toward immunotherapy as a viable … Continued
Janice Paulshock first began connecting with others in the ovarian cancer community in 1999 after being diagnosed with Stage 3C high-grade serous carcinoma. Twenty-plus years and four recurrences later, she remains committed to offering support to gynecologic cancer patients through her role as a mentor in OCRA’s Woman to Woman program. Find out how her … Continued
Get email updates about research news, action alerts, and ways to join the fight.
Our website uses cookies to ensure you get the best experience. By continuing to use this website, you indicate that you have read and agree to our Terms of Use and Privacy Policy.
